Fabrice Larosa

Title: Fabrice Larosa: Innovator in CAR-T Cell Technology

Introduction

Fabrice Larosa is a notable inventor based in Velars sur Ouche, France. He has made significant contributions to the field of biotechnology, particularly in the development of CAR-T cell therapies. His innovative work focuses on targeting specific receptors to enhance treatment options for proliferative diseases.

Latest Patents

Fabrice Larosa holds a patent for "CAR-T cells targeting IL-1RAP and their use." This invention relates to an isolated nucleic acid molecule encoding a chimeric antigen receptor (CAR). The CAR includes an antibody or antibody fragment with an anti-IL-1RAP binding domain. The patent also covers polypeptides encoded by this nucleic acid molecule, isolated CAR molecules, vectors containing the nucleic acid, and T cells that express this vector. The invention aims to utilize these T cells, whether autologous or allogeneic, to treat proliferative diseases in mammals.

Career Highlights

Throughout his career, Fabrice Larosa has worked with esteemed organizations such as the Etablissement Français du Sang and the Institut National de la Santé et de la Recherche Médicale. His experience in these institutions has contributed to his expertise in medical research and innovation.

Collaborations

Fabrice has collaborated with notable professionals in his field, including Christophe Ferrand and Marina Deschamps. These partnerships have furthered his research and development efforts in CAR-T cell technology.

Conclusion

Fabrice Larosa is a pioneering inventor whose work in CAR-T cell technology holds promise for advancing treatments for proliferative diseases. His contributions to biotechnology continue to impact the medical field positively.